HAMP promoter mutation nc.-153 C>T in 785 HEIRS Study participants: Author reply

Haematologica

Volumn 94, Issue 10, 2009, Pages 1465-1466

  Loréal, Olivier ^a,b   Jouanolle, Anne Marie ^b   Island, Marie Laure ^a   Mosser, Annick ^b   Deugnier, Yves ^a,b   David, Véronique ^a,b   Brissot, Pierre ^a,b  

^a UNIVERSITÉ DE RENNES 1   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FERRITIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; SMAD1 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

BETA THALASSEMIA; GENE MUTATION; GENETIC SCREENING; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LETTER; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 70349633600     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.013508     Document Type: Letter

References (2)

1. Island ML, Jouanolle AM, Mosser A, Deugnier Y, David V, Brissot P, et al. A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis. Haematologica 2009;94:720-724
2. Barton JC, Leiendecker-Foster C, Li H, DelRio-LaFreniere S, Ronald T. Acton RT, John H. Eckfeldt JH. HAMP promoter mutation nc.-153C>T in 785 HEIRS Study participants. Haematologica 2009;94:1464.